{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-038668","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2023-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.343319+00:00","generated_at":"2026-06-09T05:54:12.175610+00:00","sec_items":["8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Propanc Biopharma closes $40K convertible note with investor","bullets":["Closed sale of $40K convertible promissory note to an investor on Oct 29, 2023.","Note is convertible into common shares at investor's option after 180 days from issuance.","Funds were received and transaction closed on Oct 29; initially disclosed on Oct 26, 2023.","Proceeds likely for general working capital; no other material terms changed from prior disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-038668","json":"https://secwatch.observer/filing/0001493152-23-038668.json","markdown":"https://secwatch.observer/filing/0001493152-23-038668.md","text":"https://secwatch.observer/filing/0001493152-23-038668.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/0001493152-23-038668-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000149315223038668/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T05:54:12.175610+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}